Skip to main content

Table 1 Baseline characteristics of eligible China patients at Phase II and Phase III

From: Real world time trends in antithrombotic treatment for newly diagnosed atrial fibrillation in China: reports from the GLORIA-AF Phase III registry

 

Phase II

N = 1,018

Phase III

N = 1,911

Standardized difference

Age, mean (SD), yrs

67.5 (11.6)

66.8 (11.1)

–0.0658

Age group, yrs, n (%)

   

 < 65

393 (38.6)

758 (39.7)

0.0217

 65 to < 75

308 (30.3)

647 (33.9)

0.0772

 75 to < 80

157 (15.4)

280 (14.7)

−0.0216

 80 to < 85

115 (11.3)

163 (8.5)

−0.0927

 ≥ 85

45 (4.4)

63 (3.3)

−0.0584

Female, n (%)

457 (44.9)

839 (43.9)

−0.0199

BMI*, mean (SD), kg/m2

24.73 (3.9)

24.73 (3.4)

−0.0006

History of hypertension, n (%)

660 (64.8)

1259 (65.9)

0.0220

Coronary artery disease, n (%)

363 (35.7)

605 (31.7)

−0.0847

Congestive heart failure, n (%)

306 (30.1)

491 (25.7)

–0.0975

Diabetes mellitus, n (%)

203 (19.9)

440 (23.0)

0.0751

Myocardial infarction, n (%)

119 (11.7)

181 (9.5)

−0.0722

Chronic GI disease, n (%)

63 (6.2)

141 (7.4)

0.0473

Previous stroke, n (%)

115 (11.3)

250 (13.1)

0.0546

 Ischemic stroke, n (%)

54 (5.3)

215 (11.3)

0.2171

 Hemorrhagic stroke, n (%)

2 (0.2)

13 (0.7)

0.0733

 Transient ischemic attack, n (%)

22 (2.2)

47 (2.5)

0.0199

Prior interventions in AF, n (%)

   

 Cardioversion

139 (13.7)

367 (19.2)

0.1502

 Cardiac ablation

79 (7.8)

244 (12.8)

0.1656

Previous bleeding, n (%)

23 (2.3)

51 (2.7)

0.0264

CKD, n (%), CrCl < 60 mL/min

269 (26.4)

442 (23.1)

−0.0764

CHA2DS2-VASc score, mean (SD)

3 (1.6)

2.9 (1.6)

−0.0443

CHA2DS2-VASc score class, n (%)

   

 Low (score = 1 for females)

44 (4.3)

95 (5.0)

0.0308

 Moderate (score = 1 for males, 2 for females)

265 (26.0)

496 (26.0)

−0.0017

 High (score ≥ 2 for males, ≥ 3 for females)

709 (69.6)

1320 (69.1)

−0.0124

HAS-BLED score, mean (SD)

1.6 (1.1)

1.6 (1.1)

−0.0554

HAS-BLED score class, n (%)

   

 Low (score < 3)

681 (66.9)

1471 (77.0)

0.2258

 High (score ≥ 3)

176 (17.3)

336 (17.6)

0.0077

 Missing

161 (15.8)

104 (5.4)

−0.3414

Type of AF, n (%)

   

 Paroxysmal

613 (60.2)

1206 (63.1)

0.0595

 Persistent

392 (38.5)

648 (33.9)

−0.0958

 Permanent

13 (1.3)

57 (3.0)

0.1183

Categorization of AF, n (%)

   

 Symptomatic

231 (22.7)

723 (37.8)

0.3342

 Minimally symptomatic

519 (51.0)

819 (42.9)

–0.1634

 Asymptomatic

268 (26.3)

369 (19.3)

–0.1678

  1. *BMI missing for patients in Phase III: n = 24 (1.3%)
  2. The standardized difference with absolute value < 0.1 was considered as balanced between groups
  3. AF, atrial fibrillation; BMI, body mass index; CKD, chronic kidney disease; CrCl, creatine clearance; GI, gastrointestinal; SD, standard deviation